Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
JTT-654
Cat. No.:
OB0425LY-222
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
JTT-654 is a selective 11β-HSD1 inhibitor with potential applications in antidepressant and anxiolytic settings.
Synonyms:
916828-66-5; JTT-654; JTT654; JTT 654
CAS No.:
916828-66-5
Formula:
C28H33F3N4O3
Formula Weight:
530.58
Specification
Target:
11β-HSD
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
JTT-654 can be used to improve insulin resistance and non-obese type 2 diabetes by inhibiting 11β-HSD1 in adipose tissue and liver.
